Licarbazepine

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameLicarbazepine
Drug Alias Name利卡西平LicarbazapinelicarbazepinalicarbazepinumMHD +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channels blockers
TargetsSodium channels
Therapy Area/IndicationsBipolar I DisorderBipolar Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[14] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsBipolar I DisorderBipolar Disorder

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG